CANNANNEW REPORT
TORONTO–(BUSINESS WIRE)–Cybin Inc. (NEO:CYBN) (“Cybin” or the “Company”), a life sciences company focused on psychedelic pharmaceutical … Read More… The post Press Release: CYBIN Provides Update on Patent Filings & Development of Therapeutics Program first appeared on Cannabis Law Report.
Excerpt only …
READ MORE BELOW
Source : Press Release: CYBIN Provides Update on Patent Filings & Development of Therapeutics Program
reposted by Cannabis News World
You must log in to post a comment.